Toward a transgenic mouse model of remyelination

Mult Scler. 1997 Apr;3(2):80-3. doi: 10.1177/135245859700300204.

Abstract

The molecular mechanisms necessary for remyelination by oligodendrocytes remain unexplored. We previously characterized a myelin basic protein promoter-lacZ (MBP-lacZ) transgene whose expression is regulated uniquely during development, and also in pathological situations, suggesting that it may be a useful reporter of molecular mechanisms during remyelination. As a first step toward creating a transgenic mouse model of remyelination, we cultured oligodendrocytes from these transgenic mice and showed that expression of MBP-lacZ appeared in parallel with a marker of oligodendrocyte maturation, galactocerebroside (GC). In addition, basic fibroblast growth factor blocked the expression of both MBP-lacZ and GC in these cells. Therefore, expression of MBP-lacZ reflects not only the developmental stage of oligodendrocytes, but also extrinsic influences on oligodendrocytes. These data suggest that MBP-lacZ may be a useful marker in transgenic mouse models of remyelination.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain / physiology
  • Cells, Cultured
  • Coculture Techniques
  • Demyelinating Diseases / physiopathology*
  • Disease Models, Animal
  • Mice
  • Mice, Transgenic
  • Myelin Basic Protein / biosynthesis
  • Myelin Basic Protein / genetics
  • Myelin Sheath / physiology*
  • Nerve Regeneration
  • Neuroglia / cytology
  • Neuroglia / physiology
  • Oligodendroglia / cytology
  • Oligodendroglia / drug effects
  • Oligodendroglia / physiology
  • Platelet-Derived Growth Factor / pharmacology
  • Recombinant Fusion Proteins / biosynthesis
  • beta-Galactosidase / biosynthesis
  • beta-Galactosidase / genetics

Substances

  • Myelin Basic Protein
  • Platelet-Derived Growth Factor
  • Recombinant Fusion Proteins
  • beta-Galactosidase